58 reports

  • Musculoskeletal Drugs was the largest segment in the region market at 15.5% of the market worth about $6.4 billion.

Drugs For Respiratory Diseases P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A

  • Cholesterol
  • Dermatological Treatment
  • Managed Care
  • Respiratory Monitoring
  • Market Size

Particularly PDE-## and PDL-## inhibitors, the market is huge.

  • Cholesterol
  • Dermatological Treatment
  • Managed Care
  • World
  • Forecast
  • ORPHAN AND RARE DERMATOLOGY DRUGS MARKET, GLOBAL, APPROVED ORPHAN AND
  • 3.3 Highly Genericized Drugs

Stomach tests involve endoscopies (a popular technique to visualize internal body cavities) and gastrointestinal biopsies (taking a sample from inside the patient' s gastrointestinal tract for analysis).

  • Dermatological Treatment
  • World
  • AbbVie Inc.
  • Amryt Pharma plc
  • Celgene Corporation

Bile acid sequestrates lead to side effects related to the gastrointestinal tract.

  • Cardiovascular Disease
  • Cholesterol
  • Lipid Modifying Drug
  • Statins
  • AstraZeneca PLC
  • WELCHOL SWOT ANALYSIS, 2015

PLOS ONE; ##(##): ##-##.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • The Medicines Company

Scope of Business: ##.

  • Cholesterol
  • Dermatological Treatment
  • Managed Care
  • China
  • Xian-Janssen Pharmaceutical Ltd.

We are one of the nation' s Top ## health systems.

  • Managed Care
  • United States
  • Company
  • Supply
  • GlobalData's company

Scope of Business: ##.

  • Cholesterol
  • Dermatological Treatment
  • China
  • Novartis AG
  • Xian-Janssen Pharmaceutical Ltd.

Systemic tetracycline may cause gastrointestinal upset, nausea, diarrhea, and vaginal yeast infection.

  • Dermatological Treatment
  • Managed Care
  • Allergan plc
  • Galderma S.A.
  • Pfizer Inc.

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation
  • WELCHOL (COLESEVELAM HCL) SWOT ANALYSIS, 2014

GASTROINTESTINAL SIDE EFFECTS WERE THE MOST COMMON AND INCLUDED ERUCTATION, DIARRHEA, AND NAUSEA.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

Drivers and their Impact Impact on Key Customer Category Increase in Incidence of High Cholesterol Increase in Prevalence of Chronic Diseases Changes in Cholesterol Treatment Guidelines Increase in Aging Population Expected Entry of Cost- Effective OTC Versions ## ## ## ## ## Hospitals Low Low

  • Cholesterol
  • Dermatological Treatment
  • Lipid Modifying Drug
  • Statins
  • AstraZeneca PLC
  • WELCHOL (COLESEVELAM HCL) SWOT ANALYSIS, 2014

GASTROINTESTINAL SIDE EFFECTS WERE THE MOST COMMON AND INCLUDED ERUCTATION, DIARRHEA, AND NAUSEA.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • WELCHOL (COLESEVELAM HCL) SWOT ANALYSIS, 2014

GASTROINTESTINAL SIDE EFFECTS WERE THE MOST COMMON AND INCLUDED ERUCTATION, DIARRHEA, AND NAUSEA.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • WELCHOL (COLESEVELAM HCL) SWOT ANALYSIS, 2014

GASTROINTESTINAL SIDE EFFECTS WERE THE MOST COMMON AND INCLUDED ERUCTATION, DIARRHEA, AND NAUSEA.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

B-## Table of Contents iv U. S.

  • Dermatological Treatment
  • Managed Care
  • United States
  • Covidien plc
  • Smith & Nephew Plc

S##. and Rehabilitation; ##(##): ##-##.

  • Cholesterol
  • Managed Care
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SMALL MOLECULE TO ANTAGONIZE GABAA RECEPTOR FOR METABOLIC, GASTROINTESTINAL AND CARDIOVASCULAR DISORDERS - DRUG PROFILE
  • DYSLIPIDEMIA - PIPELINE BY SJT MOLECULAR RESEARCH SL, H1 2018

Dyslipidemia - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Dyslipidemia - Pipeline Review, H1 2018, provides an overview of the Dyslipidemia (Metabolic Disorders) pipeline landscape. Dyslipidemia is defined as elevation...

  • Cholesterol
  • Chronic Disease
  • Managed Care
  • Pharmaceutical
  • Amarin Corporation plc
  • PIPELINE BY EA PHARMA CO LTD, H2 2018
  • INTRODUCTION

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Dermatological Treatment
  • Pharmaceutical
  • World
  • Product Initiative
  • Gilead Sciences, Inc.
  • FRESENIUS MEDICAL CARE AG & CO KGAA, DEALS BY THERAPY AREA, 2012 TO YTD 2018

DIALYSIS TREATMENTS INCREASED BY ##%.

  • Managed Care
  • Australia
  • United States
  • Company Financials
  • Fresenius Group
  • SMALL MOLECULE TO ANTAGONIZE GABAA RECEPTOR FOR METABOLIC, GASTROINTESTINAL AND CARDIOVASCULAR DISORDERS - DRUG PROFILE
  • DYSLIPIDEMIA - PIPELINE BY SJT MOLECULAR RESEARCH SL, H2 2018

Dyslipidemia - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Dyslipidemia - Pipeline Review, H2 2018, provides an overview of the Dyslipidemia (Metabolic Disorders) pipeline landscape. Dyslipidemia is defined as elevation...

  • Cholesterol
  • Chronic Disease
  • Managed Care
  • United States
  • Amarin Corporation plc
  • Mayo Foundation for Medical Education and Research, Deals By Therapy Area, 2011 to YTD 2017

Deal Rationale Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products.

  • Cholesterol
  • Clinic
  • Dermatological Treatment
  • Managed Care
  • GlobalData's company

One unit is one oximeter sensor.

  • Managed Care
  • Respiratory Monitoring
  • United States
  • Company
  • GlobalData's company

The company' s major products include analgesics, gastrointestinal, personal care and derma therapeutics, colobetasol spray, clindamycin foam, mupirocin ointment, halobetasol ointment and cream and permethrin cream.

  • Dermatological Treatment
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States

The company' s major products include analgesics, gastrointestinal, personal care and derma therapeutics, colobetasol spray, clindamycin foam, mupirocin ointment, halobetasol ointment and cream and permethrin cream.

  • Dermatological Treatment
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States

GlobalData Prasco LLC, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Dermatological Treatment
  • Healthcare
  • Pharmaceutical
  • United States
  • Prasco, LLC
  • Respiratory Measurement Devices Companies and Product Overview

One unit is one Capnograph.

  • Clinical Trial
  • Hospital
  • Managed Care
  • Respiratory Monitoring
  • Sensor

Major gastrointestinal diseases include irritable bowel syndrome, Crohn' s disease, cirrhosis, liver diseases and hepatitis C infection (HCV), among others.

  • Health Services
  • Hospital
  • Managed Care
  • United States
  • Company

Growth in molecular biology lines was driven by the ongoing fast-paced development of FilmArray®, and in particular the Gastrointestinal and Meningitis/ Encephalitis panels.

  • Biotech
  • Cholesterol
  • Managed Care
  • United States
  • bioMerieux S.A.
  • HS-25 - Drug Profile

It is found on the gastrointestinal tract epithelial cells as well as in hepatocytes.

  • Cholesterol
  • Lipid Modifying Drug
  • United States
  • Product Initiative
  • Merck & Co., Inc.